Author: Ken Dropiewski

AIROS Medical and Fist Assist Devices, LLC Announce Launch of Commercial Website for Fist Assist FA-1 Wearable Medical Device

LAS VEGAS–(BUSINESS WIRE)–AIROS Medical, Inc., a designer, manufacturer, and distributor of compression therapy devices, and Fist Assist Devices, LLC (Fist Assist), an innovative medical device company, today announced the launch of an e-commerce website, www.fistassistusa.com, for the sale of the Fist Assist FA-1 compression device. The FDA 510(k)-cleared Fist Assist Model FA-1 […]

Economic Impact of Cook Medical’s new Indy manufacturing site estimated at $25.9 Million

Indianapolis, Ind. – Indiana University’s Public Policy Institute (PPI) estimates that Bloomington, Indiana based Cook Medical’s medical device manufacturing facility nearing completion at 38th & Sheridan in Indianapolis will have an estimated economic impact of $25.9 million annually for Marion County. The $15 million, 40,000 sq. foot facility, which plans to begin […]

The Heart Failure Society of America Releases Review Examining the Growing Economic Burden of Heart Failure in the United States

ROCKVILLE, Md., Jan. 24, 2022 /PRNewswire/ — Today, the Heart Failure Society of America (HFSA) released a review, Economic Issues in Heart Failure in the United States, in the Journal of Cardiac Failure (JCF). The review examines the growing economic burden of heart failure for patients and the health care system in the United States, providing a summary of […]

Peerbridge Health and Northwell Health Launch Pilot Program to Optimize Treatment for AFib Patients at Lenox Hill Hospital

NEW YORK, Jan. 25, 2022 /PRNewswire/ — Peerbridge Health is collaborating with Northwell Health on their newly launched AFib Center of Excellence, a mutli-displinary effort that optimizes treatment for patients with atrial fibrillation (AFib). With Peerbridge’s support, Northwell’s AFib Center of Excellence will conduct a pilot program focusing on AFib patients with undiagnosed […]

Imara Announces FDA Clearance of Investigational New Drug Application (IND) for Tovinontrine (IMR-687) for Heart Failure with Preserved Ejection Fraction (HFpEF)

Expanding patient base and potential of Imara’s small molecule oral inhibitor of phosphodiesterase-9 (PDE9) alongside hemoglobin disorders Phase 2 trial aims to select HFpEF patients with enriched PDE9 expression for targeted approach to a heterogeneous disease Study initiation planned for second quarter of 2022 BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) […]

HonorHealth Scottsdale Shea Medical Center Builds Advanced Robotic Program to Treat Heart Rhythm Disorders

ST. LOUIS, Jan. 25, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that HonorHealth has established a robotic electrophysiology program as part of its Cardiovascular Center of Excellence at HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona. HonorHealth is […]

Chiesi USA Announces New Publication of Post Hoc Analysis on Timing of Ischemic Events in Cardiac Patients and Role of KENGREAL® (cangrelor) in Reducing Risk

Post hoc analysis of the CHAMPION PHOENIX clinical trial demonstrates that the majority of ischemic events occurred early in percutaneous coronary intervention (PCI), and KENGREAL® (cangrelor) treatment significantly reduced these events in the first two hours post-randomization compared to clopidogrel (4.1% vs 5.4%, p=0.002) CARY, N.C., Jan. 25, 2022 (GLOBE […]